Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
6.88M
-
Shares change
-
+276K
-
Total reported value, excl. options
-
$181M
-
Value change
-
+$7.21M
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$26.36
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2015
47 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2015.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.88M shares
of 100M outstanding shares and own 6.85% of the company stock.
Largest 10 shareholders include FMR LLC (3.5M shares), ORBIMED ADVISORS LLC (350K shares), BlackRock Advisors LLC (343K shares), JPMORGAN CHASE & CO (300K shares), FRANKLIN RESOURCES INC (244K shares), PERCEPTIVE ADVISORS LLC (219K shares), PICTON MAHONEY ASSET MANAGEMENT (202K shares), LAZARD ASSET MANAGEMENT LLC (193K shares), GLG LLC (184K shares), and Tekla Capital Management LLC (158K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.